Health coach-supported mobile health intervention to improve adherence to lipid-lowering medications (AdLip): Design and rationale of a multicentre randomized controlled trial protocol
Open Access
- 5 May 2026
- journal article
- clinical trial-protocol
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0346509
Abstract
Background: Elevated low-density lipoprotein cholesterol is one of the major modifiable risk factors for cardiovascular disease. Lipid management is integral to primary and secondary prevention of cardiovascular disease, but undermined by high prevalence of non-adherence to lipid-lowering medications. Innovative, personalized multicomponent interventions may address the gaps in medication non-adherence. We aim to evaluate the effectiveness of a human coach-supported digital personal health assistant (mobile health app) intervention in improving adherence to statins in adults with hyperlipidaemia. Methods: AdLip is a multicentre, open-label, parallel, two-arms, randomized controlled trial aiming to recruit a minimum of 376 adult participants who are non-adherent to statins from primary care ambulatory clinic setting in Singapore. Participants recruited will be randomly assigned (1:1) to human-coach supported mobile health app intervention or control group. The primary outcome will be adherence to statins at 6 months, measured by Medication Adherence Report Scale-5. Secondary outcomes will include change in serum low-density lipoprotein cholesterol levels, health motivation and attitudes, self-efficacy, self-care behaviours, quality of life, app acceptability, user engagement, and cost-effectiveness. Outcomes will be analysed using intention-to-treat approach. Discussion: The AdLip trial will provide empirical evidence on a multicomponent approach to the long-standing challenge of suboptimal adherence to statins in a multi-ethnic Asian setting. Findings from this study may inform a more personalized approach to addressing non-adherence in the short term, and how it relates to cardiovascular disease prevention in the longer term. Trial Registration: ClinicalTrials.gov NCT06614049 .Keywords
Funding Information
- CArdiovascular DiseasE National Collaborative Enterprise (MOH-001277-01)
- National Medical Research Council (NMRC CG21APR1006)
- National Medical Research Council (NMRC/CG21APRC006)
- Ministry of Health -Singapore (MOH-STaR21jun-0003)
This publication has 49 references indexed in Scilit:
- Effectiveness of Mobile Health Intervention in Medication Adherence: a Systematic Review and Meta-AnalysisJournal of Medical Systems, 2025
- Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic ReviewPharmacoepidemiology and Drug Safety, 2024
- Outcomes of a smartphone-based application with live health-coaching post-percutaneous coronary interventionEBioMedicine, 2021
- Why digital health trials can fail: Lessons learned from a randomized trial of health coaching and virtual cardiac rehabilitationCardiovascular Digital Health Journal, 2021
- Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participantsAmerican Heart Journal, 2019
- Interventions to Improve Medication AdherenceJAMA, 2018
- The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change InterventionsAnnals of Behavioral Medicine, 2013
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen ComplexityThe American Journal of Geriatric Pharmacotherapy, 2011
- Predictors of Medication Adherence Using a Multidimensional Adherence Model in Patients With Heart FailureJournal of Cardiac Failure, 2008